Wang Xinlu

[Expert Profile] Wang Xinlu, Chief Physician, Professor, Doctoral Supervisor, National Master of Chinese Medicine, is an authoritative expert in TCM internal medicine in China, working at Shandong University of Traditional Chinese Medicine. He has long been dedicated to clinical diagnosis, treatment, and scientific research of the "blood turbidity" theory, cardiovascular and cerebrovascular diseases, diabetes, and metabolic diseases, and is an important leading figure in TCM internal medicine and TCM thinking research.

[Education & Career] Professor Wang Xinlu graduated from Shandong College of Traditional Chinese Medicine, has long been engaged in TCM internal medicine clinical and research work, and pioneered the TCM "blood turbidity" theory. He has served as President of Shandong University of Traditional Chinese Medicine and Vice Chairman of the Shandong Provincial Committee of the Chinese People's Political Consultative Conference. He received the title of "National Master of Chinese Medicine" in 2022, and holds academic positions including Vice President of the China Association of Chinese Medicine. He is a highly respected authoritative expert in the field of TCM internal medicine in China.

[Areas of Expertise] Professor Wang specializes in TCM diagnosis and treatment of cardiovascular and cerebrovascular and metabolic diseases such as coronary heart disease, hypertension, stroke, diabetes, and hyperlipidemia. The "blood turbidity" theory he created combines modern blood biochemical abnormalities with TCM pathogenesis. He has profound expertise in the "turbidity-resolving" therapeutic method and Chinese herbal lipid-lowering and hypoglycemic therapy. He excels at managing complex cases of "three highs coexisting and metabolic disorder" from the "blood turbidity" perspective, helping numerous patients improve metabolic indicators and prevent cardiovascular and cerebrovascular events.

[Academic Achievements & Industry Contributions] The TCM blood turbidity theory created by Professor Wang has opened up new approaches for TCM diagnosis and treatment of metabolic diseases. He has authored monographs such as Brain Blood Syndrome Differentiation, systematically promoting innovative TCM syndrome differentiation for modern diseases. He has led clinical research on blood turbidity theory and TCM lipid-lowering and hypoglycemic therapy, actively promoted TCM preventive treatment of disease and health management concepts, and made important contributions to TCM theoretical innovation and cardiovascular and cerebrovascular disease prevention and treatment in China.

[Clinical Practice & Outstanding Contributions] With decades of medical practice, Professor Wang has treated hundreds of thousands of cardiovascular and cerebrovascular and metabolic disease patients, with significant clinical efficacy and deep patient trust. He has received multiple national honors, trained a large number of TCM internal medicine professionals, and has been repeatedly invited to present at national academic conferences. He is an authoritative expert in the field of TCM internal medicine in China.

[Honors & Reputation] Professor Wang Xinlu holds positions at Shandong University of Traditional Chinese Medicine and serves as Vice President of the China Association of Chinese Medicine, among other academic positions. He received the title of "National Master of Chinese Medicine" in 2022, and is an authoritative expert in the field of TCM internal medicine in China. The TCM "blood turbidity" theory he created has opened up new approaches for TCM diagnosis and treatment of metabolic diseases. He has authored monographs such as Brain Blood Syndrome Differentiation, led clinical research on blood turbidity theory and TCM lipid-lowering and hypoglycemic therapy, and promoted the implementation of TCM preventive treatment of disease and health management concepts. He has trained a large number of TCM internal medicine professionals, is known for significant clinical efficacy, and is deeply trusted by patients and respected by peers alike.